Acoustic wave therapy (AWT) — also called low-intensity extracorporeal shock wave therapy (Li-ESWT) — delivers precisely focused sound waves into targeted tissue. These waves create micro-mechanical stress that triggers the body's natural repair mechanisms.
The primary mechanism is neovascularization: the formation of new blood vessels. When wave energy penetrates tissue, it activates growth factors (including VEGF and eNOS) that stimulate blood vessel regeneration. In the context of erectile dysfunction, this means restoring the penile microvascular network that diminishes with age, diabetes, and cardiovascular disease.
Multiple peer-reviewed clinical studies have demonstrated that acoustic wave therapy significantly improves erectile function scores (IIEF) in men with vasculogenic ED, with results persisting for 12–36 months after treatment.
Beyond ED, AWT is FDA-cleared for a range of musculoskeletal conditions including plantar fasciitis, calcific shoulder tendinitis, tennis elbow, and Achilles tendinopathy. The same tissue regeneration mechanism applies — stimulating collagen production, reducing calcium deposits, and restoring healthy circulation.